Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2/neu vaccine-related immunity in breast cancer patients.
Clin Cancer Res. 2006 Jan 15;12(2):478-86. doi: 10.1158/1078-0432.CCR-05-1425.
Clin Cancer Res. 2006.
PMID: 16428490
Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial.
Mittendorf EA, Storrer CE, Foley RJ, Harris K, Jama Y, Shriver CD, Ponniah S, Peoples GE.
Mittendorf EA, et al.
Cancer. 2006 Jun 1;106(11):2309-17. doi: 10.1002/cncr.21849.
Cancer. 2006.
PMID: 16596621
Free article.
Clinical Trial.
Item in Clipboard
Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Amin A, Benavides LC, Holmes JP, Gates JD, Carmichael MG, Hueman MT, Mittendorf EA, Storrer CE, Jama YH, Craig D, Stojadinovic A, Ponniah S, Peoples GE.
Amin A, et al. Among authors: jama yh.
Cancer Immunol Immunother. 2008 Dec;57(12):1817-25. doi: 10.1007/s00262-008-0509-2. Epub 2008 Apr 8.
Cancer Immunol Immunother. 2008.
PMID: 18392824
Free PMC article.
Clinical Trial.
Item in Clipboard
Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology.
Dehqanzada ZA, Storrer CE, Hueman MT, Foley RJ, Harris KA, Jama YH, Shriver CD, Ponniah S, Peoples GE.
Dehqanzada ZA, et al. Among authors: jama yh.
Oncol Rep. 2007 Mar;17(3):687-94.
Oncol Rep. 2007.
PMID: 17273752
Clinical Trial.
Item in Clipboard
Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide.
Gates JD, Clifton GT, Benavides LC, Sears AK, Carmichael MG, Hueman MT, Holmes JP, Jama YH, Mursal M, Zacharia A, Ciano K, Khoo S, Stojadinovic A, Ponniah S, Peoples GE.
Gates JD, et al. Among authors: jama yh.
Vaccine. 2010 Nov 3;28(47):7476-82. doi: 10.1016/j.vaccine.2010.09.029. Epub 2010 Sep 19.
Vaccine. 2010.
PMID: 20858449
Clinical Trial.
Item in Clipboard
Systemic cytokine response in murine anthrax.
Popov SG, Popova TG, Grene E, Klotz F, Cardwell J, Bradburne C, Jama Y, Maland M, Wells J, Nalca A, Voss T, Bailey C, Alibek K.
Popov SG, et al.
Cell Microbiol. 2004 Mar;6(3):225-33. doi: 10.1046/j.1462-5822.2003.00358.x.
Cell Microbiol. 2004.
PMID: 14764106
Item in Clipboard
Cite
Cite